Pfizer and BioNTech announced it is working on a combined COVID-19 and flu vaccine as it began trials this week.
The vaccine combines Pfizer’s quadrivalent modRNA-based influenza vaccine candidate with the companies’ omicron-adapted bivalent COVID-19 vaccine, Pfizer and BioNTech said.
While flu vaccinations have become a yearly ritual for many, it’s still not certain whether COVID-19 vaccines will be administered similarly. Some health officials have suggested it’s likely COVID-19 vaccines will be needed annually to guard against waning immunity from past infections and shots.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Pfizer-BioNTech testing combination flu-COVID-19 vaccineThe WHO estimates 290,000 to 650,000 people worldwide die of flu-related causes every year. About 1.1 million people in the U.S. have died from COVID-19.
Leer más »
Pfizer, BioNTech start COVID-flu combination vaccine studyU.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.
Leer más »
Pfizer, BioNTech launch phase 1 trial on combined COVID-19 and flu vaccinePfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and influenza, the companies announced Thursday.
Leer más »
Pfizer, BioNTech launch combo COVID-flu vaccine studyPfizer and BioNTech aim to enroll 180 U.S. volunteers between the ages of 18 and 64 for an early-stage trial to assess the safety, efficacy and optimal dosage.
Leer más »
Pfizer and BioNTech start study to test combined COVID-19 and flu vaccinePfizer and BioNTech announced Thursday they have begun an early-stage study to test a combination vaccine for COVID-19 and the flu.
Leer más »